statistiche ricercatore

GHIDINI, MICHELE

Distribuzione geografica

Continente	#
NA - Nord America	1.712
AS - Asia	1.453
EU - Europa	864
SA - Sud America	98
AF - Africa	38
Totale	4.165

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1.664
SG - Singapore	675
IT - Italia	482
CN - Cina	360
VN - Vietnam	157
FR - Francia	148
HK - Hong Kong	130
BR - Brasile	69
DE - Germania	47
GB - Regno Unito	43
IE - Irlanda	41
SE - Svezia	33
IN - India	30
BD - Bangladesh	25
RU - Federazione Russa	25
CA - Canada	23
MX - Messico	21
NG - Nigeria	20
JP - Giappone	14
FI - Finlandia	13
IQ - Iraq	11
AR - Argentina	10
NL - Olanda	9
TH - Thailandia	9
JO - Giordania	7
PL - Polonia	6
TR - Turchia	6
CO - Colombia	4
ES - Italia	4
ID - Indonesia	4
KE - Kenya	4
LT - Lituania	4
PE - Perù	4
SA - Arabia Saudita	4
VE - Venezuela	4
ZA - Sudafrica	4
AT - Austria	3
EC - Ecuador	3
AE - Emirati Arabi Uniti	2
CL - Cile	2
DZ - Algeria	2
EG - Egitto	2
IL - Israele	2
LB - Libano	2
MA - Marocco	2
MY - Malesia	2
OM - Oman	2
PK - Pakistan	2
RS - Serbia	2
TN - Tunisia	2
AZ - Azerbaigian	1
BB - Barbados	1
BH - Bahrain	1
CG - Congo	1
GR - Grecia	1
KR - Corea	1
KW - Kuwait	1
LV - Lettonia	1
ML - Mali	1
NI - Nicaragua	1
NP - Nepal	1
PH - Filippine	1
PT - Portogallo	1
PY - Paraguay	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	4.165

Salva come PNG Salva come JPEG

Città	#
San Jose	566
Singapore	398
Milan	312
Council Bluffs	155
Ashburn	149
Lauterbourg	138
Hong Kong	127
Beijing	92
Chicago	55
Dallas	50
Rome	50
Hanoi	49
New York	45
Los Angeles	42
Dublin	41
Ho Chi Minh City	40
Princeton	36
The Dalles	33
Nyköping	27
Orem	25
Boardman	24
Abuja	20
Frankfurt am Main	20
Santa Clara	20
London	17
San Diego	14
Schiffdorf	14
Tampa	13
Guangzhou	12
Houston	12
Mexico City	12
Atlanta	11
Naples	11
Brooklyn	10
Chennai	10
Denver	10
Salt Lake City	10
São Paulo	10
Fairfield	9
Helsinki	9
Montreal	9
Bangkok	8
Phoenix	8
Seattle	8
Tianjin	8
Amman	7
Chandler	7
Da Nang	7
Mumbai	7
Poplar	7
Hangzhou	6
Nuremberg	6
Shanghai	6
Tokyo	6
Turin	6
Warsaw	6
Baghdad	5
Boston	5
Chengdu	5
Elk Grove Village	5
Hải Dương	5
Ogden	5
San Francisco	5
Stockholm	5
Varese	5
Detroit	4
Haiphong	4
Paris	4
Pune	4
Shenzhen	4
Sterling	4
Woodbridge	4
Amsterdam	3
Ankara	3
Bến Tre	3
Calgary	3
Cambridge	3
Can Tho	3
Charleston	3
Cleveland	3
Covina	3
Curitiba	3
Fayetteville	3
Genoa	3
Lancaster	3
Lima	3
Medina	3
Nairobi	3
Piscataway	3
Thái Nguyên	3
Việt Yên District	3
Wakayama	3
Wilmington	3
Ann Arbor	2
Betim	2
Biên Hòa	2
Bristol	2
Bắc Ninh	2
Cairo	2
Caracas	2
Totale	2.960

Salva come PNG Salva come JPEG

Nome	#
Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis	121
A review of clinical practice guidelines and treatment recommendations for cancer care in the COVID-19 pandemic	111
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation	106
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes	92
Triage process for the assessment of coronavirus disease 2019-positive patients with cancer: The ONCOVID prospective study	77
IDH signalling pathway in cholangiocarcinoma: From biological rationale to therapeutic targeting	75
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer	74
Impact of bmi on survival outcomes of immunotherapy in solid tumors: A systematic review	74
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study	73
Targeting kras in solid tumors: Current challenges and future opportunities of novel kras inhibitors	73
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic	72
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?	71
Association of steroids use with survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis	69
Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma	69
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study	68
Impact of use of gastric-acid suppressants and oral anti-cancer agents on survival outcomes: A systematic review and meta-analysis	67
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort	65
Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts	65
Metabolic disorders and the risk of cholangiocarcinoma	64
Nivolumab plus ipilimumab for the first-line treatment of metastatic NSCLC	63
Coronavirus infection and immune system: An insight of COVID-19 in cancer patients	60
Strategies for increasing the effectiveness of aromatase inhibitors in locally advanced breast cancer: An evidence-based review on current options	59
The appropriateness of invasive ventilation in covid-19 positive cancer patients: Proposal of a new prognostic score	58
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status	56
Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer	52
Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres	46
Nanomedicine for the Delivery of RNA in Cancer	34
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer A Systematic Review and Pooled Analysis	34
Association of Obesity With Survival Outcomes in Patients With Cancer A Systematic Review and Meta-analysis	32
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?	31
Harrison. Principi di medicina interna.	31
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis	29
Better survival of patients with oligo- compared with polymetastatic cancers: A systematic review and meta-analysis of 173 studies	27
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario	27
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches	27
Body weight loss (BWL) as a prognostic/predictive factor in previously treated patients (pts) with metastatic gastric or gastroesophageal junction cancer (mGC/GEJC): Post-hoc analyses of the phase III tags trial	26
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)	26
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis	26
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer	26
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers A Systematic Review and Meta-analysis	25
Biliary tract cancer: current challenges and future prospects	25
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?	24
Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)	23
Molecular profiling of tissue and circulating cancer-related ncRNA in hepatocellular carcinoma	23
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer	23
Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer	22
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study	22
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic	22
Clinical impact of neutropenia and febrile neutropenia in mCRC pts treated with FOLFOXIRI/bevacizumab (bev): A pooled analysis of TRIBE and TRIBE2 studies	22
Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars	21
Molecular profiling of tissue- and circulating cancer related non coding RNAs in hepatocellular carcinoma	21
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study	20
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer	20
Treatment options for advanced small bowel adenocarcinoma: a systematic review	20
Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery	20
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study	19
Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies	19
Clinical development of mTor inhibitors for renal cancer	19
Effects of hypertension on cancer survival: A meta-analysis	19
New Tools for Precision and Personalized Treatment in Gastrointestinal Cancers	19
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies	19
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial	19
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients	18
Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review	18
Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study	18
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+Cells	18
Correlation between Olive Oil Intake and Gut Microbiota in Colorectal Cancer Prevention	18
Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis	18
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey	18
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study	18
Comparative Efficacy of 21 Treatment Strategies for Resectable Pancreatic Cancer: A Network Meta-Analysis	17
Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer	17
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer A Systematic Review and Meta-analysis	17
The impact of prior therapies on outcomes with trifluridine/tipiracil (FTD/TPI) in the phase III TAGS trial	17
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy	17
MicroRNA deregulation of the serine synthesis pathway controls intrinsic and non-cell autonomous mechanism of resistance to Regorafenib in metastatic colorectal cancer (mCRC)	17
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry	17
MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours	17
Population-Based Long-term Cardiac-Specific Mortality Among Patients With Major Gastrointestinal Cancers	17
The Role and Expression of Angiogenesis-Related miRNAs in Gastric Cancer	17
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and metaanalysis	17
Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer	16
Expression of exosomal let-7g in biofluids and outcome in colon cancer patient treated with anti-EGFR therapy	16
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?	16
Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis	16
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial	16
Characterisation of the immune-related transcriptome in resected biliary tract cancers	16
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST	15
An introduction to the current management of colorectal cancer in the era of personalized oncology	15
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy	15
Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis	15
Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review)	15
Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials	15
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib	15
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities	15
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma	15
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy Subgroup Analyses of a Randomized Clinical Trial	15
Predictors of Lymph Node Metastasis in T1 Colorectal Cancer in Young Patients: Results from a National Cancer Registry	15
Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340	15
Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study	15
Totale	3.364

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	21.566
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	21.566

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	81	0	0	0	0	3	0	35	4	3	2	13	21
2022/2023	115	18	4	8	2	7	29	0	10	12	17	1	7
2023/2024	423	44	77	70	89	112	4	3	3	17	4	0	0
2024/2025	299	5	4	51	4	2	23	4	4	45	33	23	101
2025/2026	3.469	40	62	44	110	411	270	912	306	669	488	157	0
Totale													4.387